NCT03491384View on ClinicalTrials.gov

Anxiety, Inflammation, Stress, and Cannabinoids

CompletedOBSERVATIONAL
Enrollment

361

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 30, 2022

Study Completion Date

May 17, 2023

Conditions
AnxietyAnxiety DisordersAnxiety GeneralizedAnxiety ChronicInflammationInflammatory Response
Interventions
DRUG

Cannabis (smoked flower, ingested edible)

Self-Directed Use (ad-libitum)

Trial Locations (1)

80304

Center for Innovation and Creativity, Boulder

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

University of Colorado, Boulder

OTHER

NCT03491384 - Anxiety, Inflammation, Stress, and Cannabinoids | Biotech Hunter | Biotech Hunter